Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS Will Require Prior Authorization For 31 Power Wheelchair Types

Executive Summary

The US Medicare agency announced will require prior authorization for 31 types of power wheelchairs in an update to its list of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) that need prior authorization as a condition of payment under Medicare.

You may also be interested in...

Medical Equipment Supplier Owner Gets 60 Months For Medicare Fraud

The owner of Royal Medical Supply was sentenced to five years in prison and ordered to pay $1.3m in restitution after submitting fraudulent claims for $4m in power wheelchairs, back braces and knee braces.

DMEPOS Prior Authorization Rule Aims To Tackle Fraud, Unnecessary Use

A new CMS rule establishes a process for requiring prior authorization for durable medical equipment, prosthetics, orthotics and supplies to tackle fraud and unnecessary use of such products.

US Senate Approves US-Mexico-Canada Agreement Championed By Industry

The US Senate overwhelmingly approved a bill on 16 January to implement the US-Mexico-Canada agreement, which includes a new chapter on the handling of medical devices supported by the medtech industry.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts